Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$154.28 USD
+1.61 (1.05%)
Updated May 16, 2024 03:59 PM ET
After-Market: $154.40 +0.12 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
JNJ 154.28 +1.61(1.05%)
Will JNJ be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JNJ
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Johnson & Johnson (JNJ) Could Be a Great Choice
Other News for JNJ
NEW YORK MARKET CLOSE: Rally stalls after Dow briefly tops 40,000 mark
The Dow just crossed 40,000 for the first time. The number is big but means little for your 401(k)
7 Upcoming Dividend Increases Including A King
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Johnson & Johnson buys eczema treatment maker for USD850 million